Felix Schumacher

Felix Schumacher

Company: Roche

Job title: Program Leader Targeted Therapeutics


Optimizing Architecture of Brain Shuttle-Antisense Oligonucleotide Conjugates for the Treatment of Neurological Disorders in In Vivo Studies 11:30 am

Aspects and conceptual design considerations of brain shuttle-ASO conjugates Analyzing the translational feasibility of this system to revolutionize potentials for clinical systemic targeting of neurological disorders Potential of peripheral administered CNS-targeting ASOsRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.